GQG Partners
ELV icon

GQG Partners’s Elevance Health ELV Stock Holding History

GQG Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,463,610
Closed -$569M – 97
2025
Q2 		$569M Buy
+1,463,610
New +$589M 0.81% 37
2023
Q3 		– Sell
-331,039
Closed -$147M – 78
2023
Q2 		$147M Sell
331,039
-1,286,544
-80% -$594M 0.34% 34
2023
Q1 		$744M Buy
1,617,583
+647,014
+67% +$308M 1.95% 21
2022
Q4 		$498M Buy
+970,569
New +$493M 1.35% 27

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

GQG Partners's ELV Position: Q3 2025 in Review

GQG Partners sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 1,463,610 shares — an estimated $569M sold.

GQG Partners first reported a position in ELV in Q4 2022 and held it in 4 quarters. The position peaked at $744M in Q1 2023. 1,511 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • GQG Partners reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • GQG Partners sold 1,463,610 Elevance Health shares in Q3 2025, an estimated $569M.
  • GQG Partners first reported a position in Elevance Health in Q4 2022 and held it in 4 quarters.
  • GQG Partners's Elevance Health position peaked at $744M in Q1 2023.
  • 1,511 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on GQG Partners's 13F filing for Q3 2025, filed 13 Nov 2025.